Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Eur Thyroid J. 2023 Jun 9;12(4). doi: 10.1530/ETJ-23-0012. Print 2023 Aug 1.
The clinical consequences of primary hypothyroidism include cardiovascular morbidity, increased mortality, and poor quality of life; therefore guidelines endorsed by several Scientific Societies recommend measuring circulating thyroid-stimulating hormone (TSH) in patients at risk. The assessment of serum TSH levels is also deemed to be the most robust and accurate biomarker during the management of replacement therapy in patients with a previous diagnosis of primary hypothyroidism. In line with a reflex TSH laboratory strategy, free thyroxine is measured only if the TSH falls outside specific cutoffs, in order to streamline investigations and save unjustified costs. This serum TSH-based approach to both diagnosis and monitoring has been widely accepted by several national and local health services; nevertheless, false-negative or -positive testing may occur, leading to inappropriate management or treatment. This review aims to describe several infrequent causes of increased circulating TSH, including analytical interferences, resistance to TSH, consumptive hypothyroidism, and refractoriness to levothyroxine replacement treatment. We propose a clinical flowchart to aid correct recognition of these various conditions, which represent important potential pitfalls in the diagnosis and treatment of primary hypothyroidism.
原发性甲状腺功能减退症的临床后果包括心血管发病率增加、死亡率增加和生活质量下降;因此,几个科学学会认可的指南建议对有风险的患者测量循环促甲状腺激素(TSH)。在对先前诊断为原发性甲状腺功能减退症的患者进行替代治疗的管理中,评估血清 TSH 水平也被认为是最可靠和最准确的生物标志物。根据反射 TSH 实验室策略,如果 TSH 落在特定截止值之外,则仅测量游离甲状腺素,以简化检查并节省不必要的成本。这种基于血清 TSH 的诊断和监测方法已被多个国家和地区的卫生服务机构广泛接受;然而,可能会出现假阴性或假阳性检测,导致不适当的管理或治疗。本综述旨在描述几种常见的循环 TSH 升高的不常见原因,包括分析干扰、对 TSH 的抵抗、消耗性甲状腺功能减退症和对左甲状腺素替代治疗的抵抗。我们提出了一个临床流程图,以帮助正确识别这些不同的情况,这些情况在原发性甲状腺功能减退症的诊断和治疗中是重要的潜在陷阱。